#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma
Click to read this study in Clinical Cancer Research.
Tag: head and neck squamous cell carcinoma
#VisualAbstract: Pembrolizumab-based therapy is more effective with increasing PD-L1 expression in head and neck squamous cell carcinomas
Click to read this study in the Journal of Clinical Oncology.
#VisualAbstract: Once-weekly cisplatin is noninferior to cisplatin every 3 weeks for postoperative head and neck cancers
Click to read this study in the Journal of Clinical Oncology.
Elevated neutrophil-lymphocyte ratio associated with poor prognosis for head and neck cancer
1. This single-centred, observational cohort study demonstrated that among patients with head and neck cancer, a high neutrophil-lymphocyte ratio (NLR) ...
#VisualAbstract: Immune checkpoint inhibitors are equally effective for younger and older patients with relapsed or metastatic head and neck squamous cell carcinomas
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Taxane monotherapy may be more effective for patients with recurrent or metastatic head and neck cancer and prior nivolumab exposure
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
#VisualAbstract: Induction chemotherapy with docetaxel, cisplatin, and cetuximab offers similar outcomes with a potentially more favorable treatment schedule than 5-fluorouracil
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Addition of pembrolizumab to chemotherapy improves survival in patients with advanced esophageal carcinomas
Click to read the study in The Lancet.
#VisualAbstract: Induction chemotherapy does not improve survival for patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Click to read the study in Nature Communications.
